GB9621836D0 - Peptide compounds - Google Patents

Peptide compounds

Info

Publication number
GB9621836D0
GB9621836D0 GBGB9621836.7A GB9621836A GB9621836D0 GB 9621836 D0 GB9621836 D0 GB 9621836D0 GB 9621836 A GB9621836 A GB 9621836A GB 9621836 D0 GB9621836 D0 GB 9621836D0
Authority
GB
United Kingdom
Prior art keywords
peptide derivatives
novel peptide
peptide compounds
compounds
dependent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9621836.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9621836.7A priority Critical patent/GB9621836D0/en
Publication of GB9621836D0 publication Critical patent/GB9621836D0/en
Priority to AT97945015T priority patent/ATE256145T1/de
Priority to AU46330/97A priority patent/AU4633097A/en
Priority to DE69726743T priority patent/DE69726743T2/de
Priority to EP97945015A priority patent/EP0932618B1/en
Priority to JP51907398A priority patent/JP2001508036A/ja
Priority to PCT/GB1997/002837 priority patent/WO1998017680A1/en
Priority to US09/284,625 priority patent/US6207644B1/en
Priority to ZA9709338A priority patent/ZA979338B/xx
Priority to TW086115279A priority patent/TW492868B/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
GBGB9621836.7A 1996-10-19 1996-10-19 Peptide compounds Pending GB9621836D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB9621836.7A GB9621836D0 (en) 1996-10-19 1996-10-19 Peptide compounds
US09/284,625 US6207644B1 (en) 1996-10-19 1997-10-14 Peptide analogues containing a 7-membered lactam ring
EP97945015A EP0932618B1 (en) 1996-10-19 1997-10-14 Peptide analogues containing a 7-membered lactam ring
AU46330/97A AU4633097A (en) 1996-10-19 1997-10-14 Peptide analogues containing a 7-membered lactam ring
DE69726743T DE69726743T2 (de) 1996-10-19 1997-10-14 Peptid analoge, die einen siebengliedrigen lactamring enthalten
AT97945015T ATE256145T1 (de) 1996-10-19 1997-10-14 Peptid analoge, die einen siebengliedrigen lactamring enthalten
JP51907398A JP2001508036A (ja) 1996-10-19 1997-10-14 ７員ラクタム環を含むペプチド類似体
PCT/GB1997/002837 WO1998017680A1 (en) 1996-10-19 1997-10-14 Peptide analogues containing a 7-membered lactam ring
ZA9709338A ZA979338B (en) 1996-10-19 1997-10-17 Peptide compounds.
TW086115279A TW492868B (en) 1996-10-19 1997-10-17 Peptide compounds useful for treating MHC class II dependent T-cell medicated autoimmune or inflammatory diseases and pharmaceutical compositions containing same, and process for preparing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9621836.7A GB9621836D0 (en) 1996-10-19 1996-10-19 Peptide compounds

Publications (1)

Publication Number Publication Date
GB9621836D0 true GB9621836D0 (en) 1996-12-11

Family

ID=10801703

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9621836.7A Pending GB9621836D0 (en) 1996-10-19 1996-10-19 Peptide compounds

Country Status (10)

Country Link
US (1) US6207644B1 (US06207644-20010327-C00004.png)
EP (1) EP0932618B1 (US06207644-20010327-C00004.png)
JP (1) JP2001508036A (US06207644-20010327-C00004.png)
AT (1) ATE256145T1 (US06207644-20010327-C00004.png)
AU (1) AU4633097A (US06207644-20010327-C00004.png)
DE (1) DE69726743T2 (US06207644-20010327-C00004.png)
GB (1) GB9621836D0 (US06207644-20010327-C00004.png)
TW (1) TW492868B (US06207644-20010327-C00004.png)
WO (1) WO1998017680A1 (US06207644-20010327-C00004.png)
ZA (1) ZA979338B (US06207644-20010327-C00004.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046578A1 (en) 1996-06-07 1997-12-11 Zeneca Limited Peptide derivatives
EP1198271A4 (en) 1999-06-25 2009-01-21 Univ Emory DEVICES AND METHODS FOR STIMULATING THE VAGUSNERVS
TW200502221A (en) 2002-10-03 2005-01-16 Astrazeneca Ab Novel lactams and uses thereof
US7439231B2 (en) * 2003-02-14 2008-10-21 Provid Pharmaceuticals, Inc. Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof
JP2006520396A (ja) * 2003-03-14 2006-09-07 アストラゼネカ・アクチエボラーグ 新規なラクタム及びその使用
TWI356821B (en) * 2003-12-01 2012-01-21 Cambridge Entpr Ltd Anti-inflammatory agents
WO2009073168A1 (en) * 2007-12-03 2009-06-11 Provid Pharmaceuticals, Inc. Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
DE3711335A1 (de) 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5223485A (en) 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
WO1992002543A1 (en) * 1990-08-01 1992-02-20 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
AU2468392A (en) 1991-08-29 1993-04-05 Cytel Corporation Novel immunosuppressants
DK0644197T3 (da) 1993-06-04 1999-06-07 Vertex Pharma Peptidphosphinyloxymethylketoner som inhibitorer af interleukin-1beta-konverterende enzymer
AU698962B2 (en) 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
AU2238395A (en) 1994-04-01 1995-10-23 Immulogic Pharmaceutical Corporation Haptenated peptides and uses thereof
JPH10508035A (ja) 1995-03-24 1998-08-04 モレキュメティックス リミテッド βシート模倣物およびプロテアーゼインヒビターとしてのその使用
WO1997016425A1 (en) 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5817757A (en) * 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
US5719296A (en) 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
US5840835A (en) * 1995-10-30 1998-11-24 Merck & Co., Inc. Inhibitors of peptide binding to MHC class II proteins
GB9702377D0 (en) 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
EP0932618A1 (en) 1999-08-04
DE69726743T2 (de) 2004-10-14
ZA979338B (en) 1998-04-20
US6207644B1 (en) 2001-03-27
TW492868B (en) 2002-07-01
WO1998017680A1 (en) 1998-04-30
EP0932618B1 (en) 2003-12-10
AU4633097A (en) 1998-05-15
DE69726743D1 (de) 2004-01-22
ATE256145T1 (de) 2003-12-15
JP2001508036A (ja) 2001-06-19

Similar Documents

Publication Publication Date Title
GB9716656D0 (en) Chemical compounds
LU91145I9 (US06207644-20010327-C00004.png)
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
TR199802537T2 (xx) Peptit t�revleri.
NZ330944A (en) Peptide derivatives
BG103417A (en) Condensed pyrimidine bicyclic derivatives
HK1051691A1 (en) Hydroxylstilbenes and stilbene derivatives and analogues of anti-inflammatory and psoriasis treatment and protein kinase inhibition
ATE229498T1 (de) Zelle adhäsion hemmenden verbindungen
MY124122A (en) Heterocyclic derivatives
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
ZA943744B (en) Therapeutic substituted guanidines
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
IL99912A0 (en) Cyclosporins,their preparation and pharmaceutical compositions containing them
SE9702001D0 (sv) Novel compounds
HK1048990A1 (en) Novel compounds.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ITMI931649A1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
AU6469401A (en) Pharmaceutically active compounds and methods of use
IL113940A (en) Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors
ZA979338B (en) Peptide compounds.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer